Cardiac stimulation at high ventricular wall stress areas

• US 7,725,185 B2
• Filed: 02/15/2008
• Issued: 05/25/2010
• Est. Priority Date: 04/27/2001
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Salo, Rodney, Liu, Lili
• Primary Examiner(s): Bockelman; Mark W
• Assistant Examiner(s): So; Elizabeth K
• Application Number:
  US12/070,080
• Publication Number:
  US 20080140144A1
• Time in Patent Office: 830 Days
• Field of Search: 607/17
• US Class Current: 607/17
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

An apparatus and method for reversing ventricular remodeling with electro-stimulatory therapy. A ventricle is paced by delivering one or more stimulatory pulses in a manner such that a stressed region of the myocardium is pre-excited relative to other regions in order to subject the stressed region to a lessened preload and afterload during systole. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling.

Claims

1. A lead implantation method, comprising:

accessing a heart of a patient, the heart having a heart wall;

detecting, proximate the heart wall, a target region of the heart wall having a level of abnormal wall motion relative to neighboring regions of the heart wall;

implanting an electrode of the lead at the target region;

pre-exciting the target region relative to the neighboring regions of the heart wall using the lead electrode in order to alter stress at the target region for treating cardiac remodeling; and

adjusting the pre-excitation in accordance with activity level measurements reflective of metabolic demand.

2. The method of claim 1, wherein the wall motion is detected using an acceleration measurement.

3. The method of claim 1, wherein the wall motion is detected using a strain measurement.

4. The method of claim 1, wherein the wall motion is detected using an ultrasonic velocity measurement.

5. The method of claim 1, wherein accessing the patient'"'"'s heart comprises accessing an epicardial surface of the patient'"'"'s heart.

6. The method of claim 1, wherein accessing the patient'"'"'s heart comprises accessing an endocardial surface of the patient'"'"'s heart.

7. The method of claim 1, wherein accessing the patient'"'"'s heart comprises accessing the patient'"'"'s heart through one or more vessels of the patient'"'"'s upper venous system.

8. The method of claim 1, wherein detecting the target region comprises sensing activation characteristics of heart wall tissue at a plurality of heart wall sites.

9. The method of claim 1, wherein detecting the target region comprises detecting one or more electrophysiologic characteristics of heart wall tissue.

10. The method of claim 1, wherein detecting the target region comprises detecting complex impedance characteristics of heart wall tissue.

11. A cardiac system, comprising:

an implantable housing;

a controller provided in the housing and configured to control cardiac monitoring and cardiac stimulation;

detection circuitry provided in the housing and coupled to the controller;

energy delivery circuitry provided in the housing and coupled to the controller; and

a lead coupled to the detection circuitry and the energy delivery circuitry, the lead comprising;

a lead body;

at least one cardiac electrode coupled to the lead body; and

at least one sensor supported by the lead body and configured to detect abnormal cardiac wall motion, the sensor providing information useful for positioning the cardiac electrode proximate a target heart wall location associated with increased stress relative to neighboring heart wall locations;

wherein the controller is configured to coordinate delivery of a pre-excitation stimulus to the target heart wall location using the cardiac electrode in order to alter stress at the target region for treating cardiac remodeling, and the controller is also configured to adjust the pre-excitation stimulus in accordance with activity level measurements reflective of metabolic demand.

12. The system of claim 11, wherein the sensor is situated at a distal region of the lead.

13. The system of claim 11, wherein the sensor comprises an accelerometer.

14. The system of claim 11, wherein the sensor comprises a strain gauge.

15. The system of claim 11, wherein the sensor comprises an ultrasonic velocimeter.

16. The system of claim 11, wherein the sensor is supported within a lumen of the lead.

17. The system of claim 11, wherein the controller coordinates delivery of the pre-excitation stimulus to the target heart wall location prior to an intrinsic conduction or delivery of a pace pulse.

18. The system of claim 11, further comprising:

an activity sensor situated in or on the housing and coupled to the controller to provide the activity level measurements.

19. A cardiac system, comprising:

an implantable lead having a lead electrode and adapted to access a heart of a patient, the heart having a heart wall;

means for detecting, proximate the heart wall, a target region of the heart wall having a level of abnormal wall motion relative to neighboring regions of the heart wall;

means for pre-exciting the target region relative to the neighboring regions of the heart wall using the lead electrode in order to alter stress at the target region for treating cardiac remodeling; and

means for adjusting the pre-excitation in accordance with activity level measurements reflective of metabolic demand.

20. The system of claim 19, wherein the implantable lead comprises at least one sensor coupled to the detecting means and configured to sense the abnormal cardiac wall motion.

21. The system of claim 20, further comprising an activity sensor coupled to the controller to provide the activity level measurements.